Patent ID: 7858610

Claim:
A method for improving bladder compliance and/or bladder capacity in a patient having interstitial cystitis, which comprises administering an effective amount of a compound selected from the group consisting of: 4-{[2-(1R,2R,3R)-3-hydroxy-2-{(1E,3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl}-5-oxocyclopentyl)ethyl]sulfanyl}butanoic acid and methyl 4-{[2-(1R,2R,3R)-3-hydroxy-2-{(1E,3S)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl}-5-oxocyclopentyl)ethyl]sulfanyl}butanoate, a salt thereof or a cyclodextrin clathrate thereof, to a patient or subject in need thereof.